Please assess the completion status of the following clinical trial:

Trial Title: Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Glaucoma or ocular hypertension in both eyes~* Currently being treated with latanoprost 0.005% daily and in need of additional IOP-lowering~* Best-corrected visual acuity of 20/100 or better in each eye~* Visual field within 6 months of study entry~Exclusion Criteria:~* Secondary glaucoma~* Active intraocular inflammation or macular edema~* Intraocular surgery or laser surgery within the past 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).